Quick Answer
LISATA THERAPEUTICS, INC. reported Long-Term Debt of $0.00 for fiscal year 2017.
LISATA THERAPEUTICS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2017 | $0.00 | -100.0% |
| 2016 | $2.52M | -76.7% |
| 2015 | $10.83M | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $3.02M | — |
| 2012 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $0.00 | -100.0% | — |
| June 30, 2017 | $0.00 | -100.0% | -100.0% |
| March 31, 2017 | $1.70M | -77.3% | -32.6% |
| December 31, 2016 | $2.52M | -76.7% | -24.2% |
| September 30, 2016 | $3.33M | -72.8% | -8.6% |
| June 30, 2016 | $3.64M | -73.3% | -51.4% |
| March 31, 2016 | $7.49M | -41.3% | -30.8% |
| December 31, 2015 | $10.83M | -22.0% | -11.6% |
- LISATA THERAPEUTICS, INC. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 22, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: